WFM
MBII

Wilmington Funds Management’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Wilmington Funds Management’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-15,929
Closed -$223K – 836
2014
Q1 		$223K Buy
+15,929
New +$250K 0.02% 637

Other funds holding MBII

WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Wilmington Funds Management's MBII Position: Q2 2014 in Review

Wilmington Funds Management sold out of Marrone Bio Innovations, Inc. (MBII) in Q2 2014, closing a stake of 15,929 shares — an estimated $223K sold.

Wilmington Funds Management first reported a position in MBII in Q1 2014 and held it in 1 quarter. The position peaked at $223K in Q1 2014. 63 funds tracked by Wall St. Rank hold MBII as of Q2 2014.

  • Wilmington Funds Management reported no remaining Marrone Bio Innovations, Inc. position as of Q2 2014 after selling out during the quarter.
  • Wilmington Funds Management sold 15,929 Marrone Bio Innovations, Inc. shares in Q2 2014, an estimated $223K.
  • Wilmington Funds Management first reported a position in Marrone Bio Innovations, Inc. in Q1 2014 and held it in 1 quarter.
  • Wilmington Funds Management's Marrone Bio Innovations, Inc. position peaked at $223K in Q1 2014.
  • 63 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q2 2014.

Based on Wilmington Funds Management's 13F filing for Q2 2014, filed 13 Aug 2014.